Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Wirden

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Journal of the International AIDS Society|January 28, 2025
Benefits of HIV-1 transmission cluster surveillance: a French retrospective observational study of the molecular and epidemiological co-evolution of recent circulating recombinant forms 94 and 132Marc Wirden, Fabienne Tombette, Sidonie Lambert-Niclot, et al.
Journal of Clinical Microbiology|January 31, 2014
Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaborationLuke C Swenson, Bryan Cobb, Anna Maria Geretti, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 3, 2019
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017Marc Wirden, Fabienne De Oliveira, Magali Bouvier-Alias, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2005
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002Diane Descamps, Marie-Laure Chaix, Patrice André, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2026
A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approvalCharlotte Charpentier, Thomas Montrouge, Marc Wirden, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2019
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?Benoit Visseaux, Lambert Assoumou, Nadia Mahjoub, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2019
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in FranceLambert Assoumou, Laurence Bocket, Coralie Pallier, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Journal of the International AIDS Society|January 28, 2025
Benefits of HIV-1 transmission cluster surveillance: a French retrospective observational study of the molecular and epidemiological co-evolution of recent circulating recombinant forms 94 and 132Marc Wirden, Fabienne Tombette, Sidonie Lambert-Niclot, et al.
Journal of Clinical Microbiology|January 31, 2014
Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaborationLuke C Swenson, Bryan Cobb, Anna Maria Geretti, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 3, 2019
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017Marc Wirden, Fabienne De Oliveira, Magali Bouvier-Alias, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 29, 2005
French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001-2002Diane Descamps, Marie-Laure Chaix, Patrice André, et al.
The Journal of Antimicrobial Chemotherapy|June 27, 2013
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2026
A French national observatory of people with HIV initiating lenacapavir-based treatment after regulatory approvalCharlotte Charpentier, Thomas Montrouge, Marc Wirden, et al.
The Journal of Antimicrobial Chemotherapy|October 24, 2019
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?Benoit Visseaux, Lambert Assoumou, Nadia Mahjoub, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2019
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in FranceLambert Assoumou, Laurence Bocket, Coralie Pallier, et al.
Pageof 10